Overview
Cystic fibrosis (CF) is a complex, life-threatening condition that affects approximately 70,000 people in the United States and over 80,000 worldwide. It is caused by mutations in the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene, which codes for a protein that regulates the movement of salt and water in and out of cells. This genetic defect leads to the production of thick, sticky mucus that clogs the airways, digestive tract, and other organs, causing a range of symptoms and complications.
CF is a multisystem disorder, meaning it affects multiple parts of the body, including the lungs, pancreas, liver, kidneys, and reproductive system. The condition is characterized by recurrent respiratory infections, digestive problems, and malnutrition, which can lead to a range of complications, including respiratory failure, liver disease, and infertility. While there is no cure for CF, advances in medical treatment and management have significantly improved the quality of life for people with the condition.
History/Background
Cystic fibrosis was first described in the 1930s by Dr. Dorothy Andersen, an American pathologist who identified the condition as a distinct entity. However, the genetic basis of CF was not understood until the 1980s, when researchers discovered the CFTR gene and identified the mutations that cause the condition. Since then, significant progress has been made in understanding the biology of CF and developing new treatments, including gene therapy, lung transplantation, and enzyme replacement therapy.
Key Information
* Prevalence: Cystic fibrosis affects approximately 1 in 2,500 to 1 in 3,500 people in the United States.
* Genetics: CF is inherited in an autosomal recessive pattern, meaning that a person must inherit two copies of the mutated gene (one from each parent) to develop the condition.
* Symptoms: Common symptoms of CF include recurrent respiratory infections, digestive problems, malnutrition, and infertility.
* Complications: Complications of CF include respiratory failure, liver disease, and infertility.
* Treatment: Treatment for CF typically involves a combination of medications, including bronchodilators, mucolytics, and enzyme replacement therapy, as well as lung transplantation and gene therapy.
Significance
Cystic fibrosis is a significant public health concern, with a high mortality rate and a range of complications that can impact quality of life. However, advances in medical treatment and management have significantly improved the outlook for people with CF, and research continues to focus on developing new treatments and improving existing ones. The Cystic Fibrosis Foundation, a leading advocacy organization, has played a critical role in promoting research, education, and awareness about CF.
